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background: Rate of reproductive aging may be related to rate of biological aging. Thus, indicators of aging, such as short telomere
length, may be more frequent in women with a history suggestive of premature reproductive senescence.
methods: Telomere-speciﬁc quantitative PCR was used to assess telomere length in two groups of women with evidence of reproduc-
tive aging: (i) patients with idiopathic premature ovarian failure (POF, N ¼ 34) and (ii) women with a history of recurrent miscarriage (RM,
N ¼ 95); and two control groups: (1) women from the general population (C1, N ¼ 108) and (2) women who had a healthy pregnancy after
37 years of age (C2, N ¼ 46).
results: The RM group had shorter age-adjusted mean telomere length than controls (8.46 versus 8.92 kb in C1 and 9.11 kb in C2,
P ¼ 0.0004 and P ¼ 0.02 for C1 and C2, respectively), although short telomeres were not conﬁned to subsets of this group known to
have experienced single or multiple trisomic pregnancies. Although sample size is limited, mean telomere length in the POF group was
signiﬁcantly longer than that in C1 (9.58 versus 8.92 kb, P ¼ 0.01).
conclusions: Women experiencing RM may have shorter telomeres as a consequence of a more rapid rate of aging, or as a reﬂection
of an increased level of cellular stress. Longer telomere length in the POF group may be explained by abnormal hormone exposure, slow cell
division rates or autoimmunity in these women. Despite small sample sizes, these results suggest that different manifestations of reproductive
aging are likely inﬂuenced by distinct physiological factors.
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Introduction
Female fertility declines with age due to the combined effects of both
a decrease in the rate of conception and an increase in the rate of
pregnancy loss due to aneuploidy (Dorland et al., 1998a).
Age-related changes in the human ovary, including depletion of
ovarian follicles (Faddy et al., 1992; Faddy, 2000) and a decline in
oocyte genomic stability leading to aneuploidy (Hassold and Hunt,
2001), may contribute to this phenomenon. The rate of female
reproductive aging displays a large amount of inter-individual variabil-
ity. This is reﬂected in the variability in age of reproductive senes-
cence (menopause) that typically occurs anytime between 40 and
60 years of age (Kato et al., 1998; te Velde and Pearson, 2002), as
well as in the individual variability in risk of conceiving a trisomic
pregnancy (Warburton et al., 2004; Nicolaides et al., 2005). This
natural variation in reproductive aging may be the result of
environmental and genetic factors that affect individual rates of
cellular aging.
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suggestion that longevity is associated with an increase in reproductive
lifespan. Mice and ﬂies selectively bred for reproductive longevity have
an overall increase in total lifespan when compared with unselected
controls (Hutchinson and Rose, 1991; Nagai et al., 1995). Human
population studies have reported that higher total fecundity (Manor
et al., 2000; Muller et al., 2002), later age at last reproduction
(Doblhammer, 2000; Muller et al., 2002; Smith et al., 2002; Helle
et al., 2005) and older age at menopause (Snowdon et al., 1989;
Cooper and Sandler, 1998; Jacobsen et al., 1999) are positively corre-
lated with longevity. A study of female centenarians found that
women living to at least 100 are greater than four times more likely to
have had a child while in their 40s than women living at age 73 (Perls
et al., 1997). There are several possible explanations for the relationship
between longevity and age at menopause: (i) prolonged estrogen
exposureassociatedwithlater menopausemayhaveapositiveinﬂuence
on life expectancy(Perlset al., 1997),(ii) effective ageof the ovarycould
directly affect longevity (Hsin and Kenyon, 1999; Cargill et al., 2003) or
(iii) selective pressures to maximize a woman’s reproductive years by
slow reproductive aging may have positively selected for women with
slower rates of cellular aging (Perls and Fretts, 2001; Perls et al., 2002).
Telomeres are a marker for cellular aging as their length declines with
each cell division. Telomere length exhibits considerable inter-individual
variation (Hastie et al., 1990) and may contribute to the observed varia-
bility in reproductive aging. Telomere variability may be due to differ-
ences in telomere length at conception, telomerase activity during
early development, rate of cell division and rate of telomere loss per
cell division. Shorter telomeres may limit the mitotic capacity of primor-
dial germ cells during fetal development and therefore restrict the size of
the follicular pool (Keefe et al., 2006). Studies examining telomere
length and reproductive aging in humans have produced contradictory
results in which telomere length has been both positively and negatively
associated with different measures of reproductive aging (Dorland et al.,
1998a; Aydos et al., 2005; Keefe et al., 2007).
Given the links between reproductive aging and biological aging, and
the potential inﬂuence of telomere length on oocyte quality, we
hypothesized that women who display evidence of premature repro-
ductive aging will have a shorter average telomere length than control
women. The objective of this study was to assess telomere length in
peripheral blood leukocytes in two groups of women with evidence
of premature reproductive aging: (i) patients with idiopathic premature
ovarian failure (POF) who experienced menopause before 40 years of
age and (ii) women with a history of recurrent miscarriage (RM), and
two control groups: (1) women from the general population not
selected on the basis of reproductive history and (2) women who
had had a healthy pregnancy after the 37 years of age and had not
experienced any pregnancy loss. This latter group may represent
women with potentially slower rates of reproductive aging, as they
have not experienced difﬁculties conceiving or maintaining pregnancy
despite a relatively advanced reproductive age.
Materials and Methods
Samples
Women with RM (N ¼ 95), deﬁned as three consecutive miscarriages of
,20 weeks of gestation, were ascertained through the Recurrent
Pregnancy Loss Clinic at the Women’s Health Centre of British Columbia.
These 95 women had a total of 458 miscarriages, and of those, 167 were
karyotyped. Karyotyped miscarriages consisted of 72 diploid losses, 71
aneuploid losses and 24 other anomalies, including polyploidy, sex
chromosome aneuploidies and translocations. Of those women with
aneuploid losses, there were 32 women who had a single trisomic miscar-
riage (ST) and 17 women who had multiple trisomic miscarriages (MT).
POF patients (N ¼ 34) with idiopathic secondary amenorrhea were ascer-
tained from the POF Clinic at the Women’s Health Centre of British
Columbia. POF diagnosis was made based on the absence of menses
for at least 3 months and two serum FSH results of .40 mIU/ml obtained
more than 1 month apart, prior to 40 years of age. Two control groups
were used in this study: Control group 1 (N ¼ 108) consisted of healthy
women of reproductive age, ranging from 17 to 55 years, and Control
group 2 (N ¼ 46) consisted of women who have had a healthy pregnancy
over 37 years of age with no history of infertility or miscarriage. DNA was
obtained by standard salt extraction from 5 ml of blood collected in
EDTA tubes. The collection of the DNA samples for this study was
obtained after informed consent and approved by the University of
British Columbia Clinical Ethics Review Board, approval number
CO1-0460.
Telomere length
Average relative telomere length was determined by quantitative PCR
(qPCR) (Cawthon, 2002). Ampliﬁcation of the telomeric repeat region
was expressed relative to ampliﬁcation of 36B4, a single copy house-
keeping gene on chromosome 12. This telomere to single copy (T/S)
ratio is proportional to the average telomere length of the sample, due
to the ampliﬁcation being proportional to the number of primer
binding sites in the ﬁrst cycle of the PCR reaction (Cawthon, 2002).
The protocol was performed as described by Cawthon (2002) with
several modiﬁcations; ampliﬁcations were carried out in 20 ml reaction
with 5n g g e n o m i c D N A , 0 . 5mM ROX Reference Dye (Invitrogen,
Carlsbad, USA) and 0.2  SYBR Green I nucleic acid gel stain in dimethyl-
sulfoxide (Invitrogen). Samples were run in triplicate on 96-well plates
containing a standard curve constructed with reference DNA serially
diluted to concentrations from 10 to 0.625 ng. A no-template control
and both short- and long-telomere reference samples were run on
each plate as quality controls. Dissociation melting curves were run
after each sample to ensure ampliﬁcation of a single species. Replicates
of each plate were done to ensure reliable values were ascertained.
The values between both runs were signiﬁcantly correlated, with a
correlation coefﬁcient of r ¼ 0.49 (P , 0.0001). To improve the
accuracy of our estimates for each individual blood sample, we averaged
the values of the two independent measurements. When values were
discrepant between the two runs by more than 0.2 SDs, subsequent
runs were done and an average of all values was used in further data
analysis.
The telomere-speciﬁc qPCR assay was validated using DNA extracted
from leukocyte cell pellets following ﬂow ﬂuorescence in situ hybridiz-
ation (FISH) (N ¼ 12) (Baerlocher et al., 2006). There was a strong
correlation between the qPCR T/S ratio and the ﬂow-FISH telomere
lengths (r ¼ 0.96). The strong correlation obtained validates the
use of an average measurement of T/S values as an accurate reﬂection
of telomere length. T/S values were converted to kilobases (kb)
using the linear equation from this correlation (y ¼ 7.25 x þ 2.50). As
expected the y-intercept is at 2.5 kb since the ﬂow-FISH assay was
calibrated using Southern blot telomere restriction fragment
lengths, which includes 2.5 kb of subtelomeric repeat (Baerlocher
et al., 2006).
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Rate of telomere decline was determined by linear regression analysis, and
one-tailed t-tests were used to determine the signiﬁcance of the regression
because of the a priori hypothesis that telomere length was associated with
age. Yearly rates of telomere decline were compared using two-tailed
t-tests for comparison of regression slopes. Mean telomere length com-
parisons between sample groups were determined using pairwise analysis
of covariance (ANCOVA) tests to adjust for differences in ages between
sample groups.
Results
Telomere length in Control group 1 signiﬁcantly declined with age
(P ¼ 0.001, one-tailed t-test) at a rate of 40 bp per year [95% conﬁ-
dence interval (CI) ¼ 14–66 bp], although there was signiﬁcant varia-
bility in telomere length at any given age (R
2 ¼ 0.081, Table I,
Supplementary Fig. 1). There was also a weak (R
2 ¼ 0.161) but signiﬁ-
cant negative association between telomere length and age in POF
patients (P ¼ 0.01, one-tailed t-test), but not in Control group 2 or
the RM group as a whole. Subsets of the RM group who have experi-
enced ST or MT are of particular interest, as incidence of trisomic
pregnancy increases with age, contributing to the age-related increase
in RM. There was a weak (R
2 ¼ 0.130) but signiﬁcant relationship
between telomere length and age in the ST subset of the RM group
(P ¼ 0.02, one-tailed t-test) but not the MT subset (Table I,
Supplementary Fig. 2). However, in no sample group was the rate
of telomere decline signiﬁcantly different from that of Control group
1 (two-tailed t-tests for comparison of regression slopes), thus
ANCOVA was used to adjust for age effects on mean telomere
length for further comparisons of mean telomere length between
groups.
Mean telomere length and age-adjusted mean telomere length for
each sample group are shown in Table II. Although women in
Control group 2 had longer age-adjusted mean telomere lengths
than those in Control group 1, this difference was not signiﬁcant.
The RM group had shorter age-adjusted mean telomere length than
Control group 1 (8.46 versus 8.92 kb, P ¼ 0.0004) and this was also
apparent in comparison with Control group 2 (9.11 kb, P ¼ 0.02).
However, short telomeres were not speciﬁcally conﬁned to the
subset of this group that had had either a single trisomy or multiple
trisomic pregnancies. Contrary to expectation, age-adjusted mean
telomere length in the POF patient group was longer than that in
Control group 1 (9.58 versus 8.92 kb, P ¼ 0.01), although this was
not signiﬁcant in comparison with Control group 2.
Discussion
Telomere-speciﬁc qPCR was used to assess telomere length in groups
of women with a reproductive history suggestive of premature
.........................................................................
.............................................................................................................................................................................................
Table I Rate of telomere loss per year in women with evidence of premature reproductive aging and controls
Sample group N Age range (years) Rate of telomere decline (base pairs/year) R
2a P-value
b
Mean Lower 95% CI Upper 95% CI
Control group 1 108 17–55 240 266 214 0.081 0.001
Control group 2 46 37–54 26 256 107 0.009 0.26
POF patients 34 21–50 298 2178 217 0.161 0.01
RM 95 24–45 23 240 40 0.000 0.44
Single trisomy 32 24–44 256 2110 22 0.130 0.02
Multiple trisomy 17 33–44 223 2150 105 0.010 0.35
CI, conﬁdence interval; POF, premature ovarian failure; Control group 1, women from the general population; Control group 2, women who had a healthy pregnancyafter 37 years of age.
aR
2 is a measure of the goodness of ﬁt of the regression.
bP-values are based on a one-tailed test for signiﬁcance of the regression based on the t-distribution.
......................................................................
.............................................................................................................................................................................................
Table II Raw and age-adjusted mean telomere length
Sample group N Mean age (years) Mean telomere length P-value
a,b
Raw data (+ + + + +SD) (kb) Age-adjusted (kb)
Control group 1 108 36.3 8.98+1.15 8.92
Control group 2 46 41.5 8.99+1.03 9.11 0.36
POF patients 34 35.4 9.61+1.38 9.58 0.01, 0.32
RM 95 35.8 8.47+0.92 8.46 0.0004, 0.02
Single trisomy 32 36.3 8.80+0.78 8.80 0.39, 0.26
Multiple trisomy 17 39.3 8.42+0.69 8.52 0.11, 0.06
aP-values in comparison with Control groups 1 and 2, respectively.
bAnalysis of covariance (k ¼ 2 in comparison with Control group 1 or 2) was used to adjust raw telomere length data by age in comparisons between groups.
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associated with reproductive aging. As hypothesized, women experi-
encing RM had a shorter age-adjusted mean telomere length than
control women, although this effect was not speciﬁcally conﬁned to
women with trisomic pregnancies. In contrast, POF patients had a
longer age-adjusted mean telomere length than that of controls. The
high variability in telomere length at any given age and the rate of tel-
omere length decline with age have been previously reported in many
control populations (Hastie et al., 1990; Slagboom et al., 1994;
Benetos et al., 2001). In this study, the relationship between telomere
length and age was not signiﬁcantly different than zero in all sample
groups, perhaps reﬂecting the limited age range in some groups.
Regardless, none of the groups had a signiﬁcantly different rate of tel-
omere decline than that of controls.
The observed shorter average telomere length in women with RM
and the trend of longer telomere lengths in women in Control group 2,
whohavehadviablepregnancieslateintheirreproductivelife,areconsist-
ent with the hypothesis that telomere length is a determinant of the rate
of reproductive aging in women. Previous studies have reported that tel-
omere length is a strong predictor of developmental potential of sister
oocytes from women undergoing IVF (Keefe et al., 2007) and is also cor-
related with reproductive lifespan in women (Aydos et al., 2005). Short
telomere length in telomerase-deﬁcient mice is associated not only
with premature aging but also with reduced fecundity leading to sterility
(Liu et al., 2002). These mice exhibit impaired oogenesis and mimic the
humanage-relateddeclineinoocytequality,withincreasedratesofapop-
tosis of the oocytes, impaired chromosome synopsis and recombination
and increased likelihood of non-disjunction and aneuploidy (Liu et al.,
2004). Young mothers of children with Down’s syndrome have normal
telomere lengths (Dorland et al., 1998b), suggesting that predisposition
to non-disjunction may not be the explanation for the ﬁnding of shor-
tened telomeres in women with RM. Although, the telomere length of
peripheral blood cells may not necessarily reﬂect that of oocytes or
embryos. Psychological stress indicated by physiological stress markers
has also been shown to negatively inﬂuence telomere length (Epel
et al., 2004) due to an increased rate of cell turnover and increased
exposure to reactive oxidative species. The shorter telomere lengths in
women with RM may therefore reﬂect higher levels of psychological
and physiological stress and/or constitutionally shortened telomeres.
The ﬁnding of increased telomere length in POF patients does not
support the hypothesis that these women have accelerated cellular
aging. As this is a relatively small sample size and the ﬁndings were
not highly signiﬁcant, it is possible that these results are due to a
type 1 error. Although care must be taken in conclusions drawn
from this data, and the necessity for additional study in this area
must be emphasized, these ﬁndings are nonetheless intriguing. One
explanation for the increase in telomere length observed in the POF
cohort may be a constitutional genetic tendency toward an overall
slower rate of cell division, perhaps by predisposing toward a pro-
longed cell cycle. A slower cell division rate in the developing ovary
could lead to the establishment of a reduced follicular pool during
early embryonic development, whereas fewer cell divisions in hemato-
poietic stem cells could result in longer telomeres measured in periph-
eral blood. If longer telomeres in blood reﬂect fewer mitotic divisions
in the initial germ cell pool, this could explain a smaller follicular pool
and early menopause in POF patients (Dorland et al., 1998a). A
second possibility is that longer telomeres in the POF patients are a
result of autoimmunity in these women. Autoimmune destruction of
the ovaries is a common cause of POF (Goswami and Conway,
2005), and autoimmunity could conceivably alter blood cell compo-
sition to a cell type with longer telomeres. However, the limited exist-
ing evidence on telomere length and autoimmunity suggests that
autoimmune conditions are associated with shorter rather than
longer telomeres (Jeanclos et al., 1998), making this a less likely
explanation.
Alternatively, longer telomeres in the POF patient group may be the
result of abnormal hormone exposure in these women. POF patients
in our study may have been exposed to elevated estrogen levels as a
result of recruitment of large cohorts of oocytes in menstrual cycles
occurring prior to POF onset. Premature follicular pool exhaustion
resulting from the continual recruitment of large cohorts of follicles
prior to menopause has been proposed as one mechanism for POF
(Pal and Santoro, 2002). Estradiol is secreted from developing follicles
(Havelock et al., 2004) and stimulated estrogen level is correlated with
the size of the antral follicle cohort (Scheffer et al., 2003). If abnormally
large follicular cohorts were recruited while POF patients were still
cycling, this could lead to elevated estrogen levels with a positive inﬂu-
ence on telomere length. This positive inﬂuence on telomere length
prior to the onset of POF may be reﬂected later in life in the form
of long telomeres after POF diagnosis. On the other hand, mainten-
ance of telomere length may be a recent phenomenon in these
women, resulting from hormone replacement therapy following POF
diagnosis. Although we lack the clinical details to assess this possibility
in our POF population, this hypothesis is supported by the ﬁnding that
long-term hormone replacement therapy in post-menopausal women
slows the rate of telomere attrition (Lee et al., 2005). Two mechan-
isms by which estrogen may positively regulate telomere length have
been proposed: (i) estrogen may ameliorate the negative effects of
reactive oxygen species (Aviv et al., 2005) which reduce telomere
length by inducing single strand breaks (von Zglinicki, 2000) and (ii)
estrogen may stimulate telomerase activity (Aviv et al., 2005).
Ovarian telomerase activity is reportedly low in POF patients with fol-
licular depletion, but high in POF patients with ovarian dysfunction and
normal follicle counts (Kinugawa et al., 2000). Since follicle count is
correlated with circulating estrogen level (Vital-Reyes et al., 2006),
this supports the suggestion that telomerase activity is inﬂuenced by
estrogen exposure, at least at the ovary.
There are several limitations to this study that must be considered.
Telomere length varies among blood cell types (Lansdorp, 2006);
therefore variability between individuals in telomere length measured
in peripheral whole blood may be a consequence of differences in
blood cell composition. Furthermore, telomere length measured in
peripheral blood may not necessarily reﬂect telomere length in the
ovary or developing embryo. However, there is a strong correlation
between telomere lengths from tissues of a single individual (Butler
et al., 1998) suggesting that telomere lengths measured in whole
blood may be an accurate proxy for telomere length at the ovary.
Small sample sizes and limited clinical details (including incomplete kar-
yotype information on the losses of RM group and no details on repro-
ductive history of the Control group 1) restrict the ability to subdivide
sample groups into more homogeneous phenotypes, and negatively
impact the power of these analyses.
RM, trisomic pregnancy and POF have all been considered
measures of premature reproductive aging. However, the observation
Telomere length and reproductive aging 1209that RM and POF showed opposite associations with telomere length,
and trisomic pregnancy showed no evidence of an association,
suggests that these different types of reproductive aging are likely inﬂu-
enced by unique factors. Further studies are necessary to conﬁrm
these ﬁndings in larger more precisely deﬁned populations, examine
the physiological mechanisms that inﬂuence both telomere length
and reproductive aging and investigate the molecular mechanisms
responsible for longer telomere lengths in the POF population.
Supplementary Data
Supplementary data are available at http://humrep.oxfordjournals.org.
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